Medical
| Tue 26 May 2026
Taipei, May 27 -- Merck Sharp & Dohme has filed a patent application for IL-2 Muteins for Treating Autoimmune and Inflammatory Diseases. This invention was developed by Alves Stephen E, Azadi Glareh, Beaumont Maribel, Benso Lia, Cheng Alan C, Georgiev Peter, Hall Brian E, Juan Veronica M, Moore Renee, Sriraman Venkataraman and Z..